InvestorsHub Logo
Followers 467
Posts 26931
Boards Moderated 2
Alias Born 09/11/2006

Re: None

Thursday, 04/22/2010 6:41:30 PM

Thursday, April 22, 2010 6:41:30 PM

Post# of 2295
4:32PM Affymax instituted a quiet period to curtail discussions in connection with the analysis of Phase 3 results for Hematide (AFFY) 24.24 -0.32 : Co announced that it has instituted a quiet period to curtail discussions with the investor community and the media in connection with the analysis of Phase 3 results for the investigational drug, Hematide, in four clinical trials (PEARL 1, PEARL 2, EMERALD 1 and EMERALD 2) which evaluated Hematide for the treatment of anemia in chronic renal failure patients.


surf's up......crikey